🚀 Exciting News! Introducing TransHeps, a cutting-edge spin-off from the University of Zurich, specializing in groundbreaking laboratory services and advisory expertise for Drug-Induced Liver Injury (DILI) in clinical trials. 🌐 Our Vision: Improve safety during drug therapy by focusing on patient-specific DILI, a rare but potentially life-threatening side effect. 🔍 Our Mission: Make MetaHeps assay a breakthrough tool for DILI causality assessment in clinical studies, serving global pharma developers and regulators. 🛠️ Products & Services: 1. Expert Advisory Services & Consulting around DILI, 2. Exclusive provider of the MetaHeps assay, 3. Tailormade mechanistic in-vitro studies to investigate DILI. 🌟 Differentiation: MetaHeps DILI causality assessment in clinical studies is unrivaled! We are the only industrial service provider of the MetaHeps assay. 👩🔬 Our Team: Seasoned scientists with proven expertise in clinical and experimental hepatology, ensuring top-tier quality standards. 📣 Join us in revolutionizing drug therapy safety! Learn more: https://transheps.com/
| Website | https://transheps.com/ |
| Employees | 3 (0 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
| Keywords | Advisory Services, Laboratory Services, Pharmaceutical Consulting, In Vitro Studies, Clinical Pharmacology, Drug Development, In Vivo Studies, Drug Metabolism, Toxicology, Clinical Trial Support, Scientific Consulting, Preclinical Studies, Regulatory Compliance, Medical Research |
Looking for a particular TransHeps employee's phone or email?
TransHeps Questions
